Evidence map›Paper›PMID 41738632›Full record

SynthesisActa obstetricia et gynecologica Scandinavica2026

Does preimplantation genetic testing for aneuploidy improve live birth rate in women diagnosed with recurrent implantation failure: A systematic review and meta-analysis?

Amy Newnham, Charlotte Leeson, Fatima Trunkwala, Joshua Odendaal, Siobhan Quenby

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amy NewnhamDivision of Biomedical Science, Clinical Research Laboratories, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0009-0000-7656-6201
Charlotte LeesonDepartment of Applied Health Sciences, School of Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID 0000-0003-4735-2452
Fatima TrunkwalaUniversity Hospitals Coventry and Warwickshire, Coventry, UK.
Joshua OdendaalDivision of Biomedical Science, Clinical Research Laboratories, Warwick Medical School, University of Warwick, Coventry, UK.
Siobhan QuenbyDivision of Biomedical Science, Clinical Research Laboratories, Warwick Medical School, University of Warwick, Coventry, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe prevalence of unexplained recurrent implantation failure (RIF) is reported as 2%-15% in the literature. The variation in prevalence reflects the heterogeneity in definition. Recent work has suggested unexplained RIF is unlikely to be endometrial or cycle synchronicity related but is, in fact, an embryological phenomenon. The most likely embryological phenomenon is aneuploidy. Preimplantation genetic testing for aneuploidy (PGT-A) has proven to reduce miscarriage rates in almost all infertility patients, including those with recurrent pregnancy loss, suggesting aneuploidy plays an important role in unsuccessful in vitro fertilization. No guidance for PGT-A use in RIF exists. This review aimed to address this evidence gap. MATERIAL AND

methodsA systematic search of Medline, Embase, Web of Science, CINAHL, and Cochrane Database from inception until November 2024 was undertaken. Selection criteria included experimental and observational studies comparing euploid blastocyst transfer using PGT-A to standard care. The population included those with RIF or undergoing a minimum of three transfers. The primary outcome was cumulative live birth rate (CLBR). The primary aim of this review is to evaluate the impact of PGT-A on live birth rate (LBR) following a diagnosis of RIF. The secondary aim was to estimate the true prevalence of RIF, using a definition of three failed cycles. A random effects meta-analysis was conducted reporting pooled odds ratios between groups using IBM SPSS v29.0.2.0 (20). The review was prospectively registered on PROSPERO:CRD42024580037.

resultsA total of 13 studies were included with low-to-moderate risk of bias. Eleven studies addressed PGT-A after an RIF diagnosis while two studies addressed RIF prevalence after successive PGT-A cycles. Four studies reported a statistically significant increase in CLBR with OR 4.23 [95% CI: 2.14, 8.38]. Similar results were seen in studies reporting a single embryo transfer using PGT-A following an RIF diagnosis, OR 2.79 [95% CI: 1.90, 4.10].

conclusionsPGT-A results in a statistically significant increase in both LBR per embryo transfer and CLBR per cycle. This finding supports the hypothesis that RIF may be an embryological phenomenon. Further research is required before routine recommendation of PGT-A for the management of RIF can be inferred.

Indexed as

Abortion, HabitualAneuploidyEmbryo ImplantationGenetic TestingLive BirthPreimplantation DiagnosisBirth RateEmbryo TransferFemaleFertilization in VitroHumansPregnancyeuploid blastocystimplantationlive birthpreimplantation genetic testing for aneuploidyrecurrent implantation failure

Identifiers

PMID41738632
PMCPMC13140667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.